IFN-β is primarily employed in the management of multiple sclerosis, while IFN-α is indicated for certain infections, like chronic hepatitis B and C infections [41,42], particularly when used in conjunction with ribavirin, an antiviral agent [43]. The gene discussed is IFNB1; the disease is infection.